missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 11364413

E2F4 Monoclonal Antibody (4E2F04 (WUF10)), Invitrogen™

Mouse Monoclonal Antibody

Brand:  Invitrogen MA511276

Product Code. 11364413

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
 View alternative products »

This item is not returnable. View return policy

Description

Description

MA5-11276 targets E2F-4 Transcription Factor in GS, IF, IHC (P), and WB applications and shows reactivity with Human and Rat samples. The MA5-11276 immunogen is recombinant human E2F-4 protein.

E2F4 Monoclonal antibody specifically detects E2F4 in Human, Mouse, Rat samples. It is validated for Gel Shift, Immunohistochemistry (Paraffin), Western Blot.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

E2F4
Monoclonal
0.2 mg/mL
PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4
Q16254, Q8R0K9
E2f4
Recombinant human E2F-4 protein
500 μL
Primary
Human, Mouse, Rat
Antibody
IgG1
Gel Shift, Immunohistochemistry (Paraffin), Western Blot
4E2F04 (WUF10)
Unconjugated
E2f4
2010111M04Rik; AI427446; E2F transcription factor 4; E2F transcription factor 4, p107/p130-binding; E2F4; E2F-4; p107/p130-binding protein; transcription factor E2F4
Mouse
Protein G
RUO
100360427, 104394, 1874
4° C
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.